At Davos 2026, Novartis CEO Vas Narasimhan said regulatory clarity in the US and a rapid reshaping of the company’s supply ...
The Trump administration’s announcement of the first MFN agreement is a major drug pricing policy milestone. Industry and policymakers await the release of the administration’s Global Benchmark for ...
The Trump Administration has announced its desire to impose price controls on drugs – officially called a most favored nation (MFN) policy. Essentially, the policy sets the price for the targeted ...
On July 31, the Trump administration called on drug manufacturers to lower prescription drug prices in the U.S. to "most favored nation" – or MFN – pricing, the lowest cost paid for the same ...
Earlier this year, when the administration proposed deep cuts to the National Institutes of Health, lawmakers from both parties swiftly and rightly pushed back. Slashing medical research funding, they ...
President Donald Trump sent letters July 31 to the CEOs of 17 major drug manufacturers doing business in the U.S., giving them 60 days to comply with his May 12 executive order (EO) on ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results